Gracell Biotechnologies Inc

GRCL:NASDAQ
RT Quote | NASDAQ | USD
Last | 4:00 PM EST
24.00quote price arrow down-0.60 (-2.44%)
Volume
601,697
52 week range
22.30 - 28.88

...

Loading . . .

KEY STATS

  • Open24.28
  • Day High24.88
  • Day Low23.74
  • Prev Close24.60
  • 52 Week High28.88
  • 52 Week High Date01/08/21
  • 52 Week Low22.30
  • 52 Week Low Date01/08/21
  • Market Cap314.64M
  • Shares Out13.11M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-54.53
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-24.91M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)24.60%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Gracell Biotechnologies Inc News

Latest GRCL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Related Video

VIDEO2:1202:12
Gracell Biotechnologies CEO sees U.S.-China tension's impact minimized

Profile

MORE
Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to deliver younger, less exhausted T cells for autologous cell therapies with...
Address
Building 3
418 Guilin Road, Xuhui District
Shanghai, SHA
200030
China